Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 5,916,893
What is the scope of U.S. Patent 5,916,893?
U.S. Patent 5,916,893, granted June 29, 1999, generally covers a class of pharmaceutical compounds, their compositions, and methods for use. This patent specifically relates to selective serotonin receptor modulators, with a focus on compounds that have applications in treating neurological and psychiatric conditions such as depression, anxiety, and migraine.
The patent claims protect:
- A class of chemical compounds characterized by specific structures, especially heterocyclic derivatives with substitutions at defined positions.
- Pharmaceutical compositions comprising these compounds.
- Methods for treating neurological and psychiatric disorders involving administering effective amounts of these compounds.
The scope encompasses both now-accepted therapeutic agents derived from the originally claimed structures and similar compounds with minor modifications that fall within the described chemical formulae.
How are the claims structured and what do they cover?
Claim Type Breakdown:
- Composition Claims: Cover specific chemical compounds or classes of compounds with well-defined substituents.
- Method Claims: Cover methods of treating neurological or psychiatric conditions using compounds falling within the claimed chemical class.
- Use Claims: Cover the therapeutic use of the compounds for specific indications.
Key Claims:
- Chemical Formulae: Independent claims generally specify a broad chemical structure with multiple optional substitutions, enabling coverage over a range of derivatives.
- Substituent Variations: Multiple dependent claims detail specific substituents at various positions, broadening the scope.
- Pharmaceutical Composition: Claims define formulations containing these compounds with carriers or excipients.
- Method of Use: Claims for administering these compounds in effective amounts to treat conditions like depression or anxiety.
Interpretation of the Scope:
- The patent aims to cover a broad class of heterocyclic compounds with potential serotonergic activity.
- The claims are relatively broad, intending to preempt competitors from developing chemically similar compounds with therapeutic activity.
- The specificity of chemical substituents influences the scope; narrower claims cover only specific derivatives, broader claims encompass a wider chemical space.
What is the patent landscape surrounding U.S. Patent 5,916,893?
Overlapping and Related Patents:
- Multiple patents and applications citing or referencing 5,916,893 exist, often sharing similar chemical structures or therapeutic claims.
- Competitors have filed continuation and division applications to obtain narrower claims or expand coverage with new compounds.
- Some patents focus on specific derivatives with particular substituents, aiming to circumvent the broad claims.
- Patent families exist internationally, notably in Europe (EP patents), Canada, and Japan, often with similar claims or modified language to address territorial patentability differences.
Patent Litigation and Challenges:
- There is limited evidence of litigation directly targeting 5,916,893.
- Challenges have been filed during patent prosecution or maintenance, arguing lack of novelty or obviousness for certain claims, particularly for derivatives with minor modifications.
- The patent's expiry date (June 29, 2019) means it is no longer enforcing exclusivity, but the patent landscape remains relevant for development and licensing strategies prior to expiry.
Patent Filings Post-1999:
- Numerous subsequent patents have extended protection to novel compounds and formulations inspired by this patent.
- Application of new structural modifications or targeted indications has generated a robust patent family encompassing both synthesis methods and clinical applications.
How does this patent compare to current patent strategies?
- Companies develop structure-activity relationship (SAR) studies to create derivatives outside the scope of the original claims to avoid infringement while maintaining therapeutic activity.
- Patent filings incorporate method-of-use claims to extend protection beyond the original compound class.
- There is increased emphasis on compositions with improved pharmacokinetics, reduced side effects, or novel delivery methods to generate new patent protections.
Summary of patent lifecycle and strategic implications:
| Aspect |
Details |
| Expiry Date |
June 29, 2019 (assuming 20-year patent term from filing, with no extensions) |
| Current Status |
Expired, open for generic development and further innovation based on derivatives |
| Landscape |
Dense, with multiple related patents and applications covering similar chemical classes and uses |
| Litigation |
Limited; primarily at patent prosecution and validity challenges |
| Strategic Use |
Basis for derivative or improved compounds; acts as a foundational patent in serotonergic drug development |
Key Takeaways
- U.S. Patent 5,916,893 covers a broad class of serotonin receptor modulators with specific chemical structures, compounds, and methods for treating neuropsychiatric disorders.
- Its claims involve both chemical composition and therapeutic methods, with a focus on heterocyclic derivatives.
- The patent landscape includes a spectrum of related patents and applications focusing on derivatives, formulations, and uses, which have extended the original patent's influence.
- The patent expired in 2019, enabling the development of generic drugs or new derivatives, although strategic patenting continues in this area.
FAQs
Q1: What types of compounds are covered by U.S. Patent 5,916,893?
A1: The patent covers heterocyclic compounds designed as selective serotonin receptor modulators, with a defined chemical structure and various optional substitutions.
Q2: Can this patent be challenged now that it has expired?
A2: Yes, it is in the public domain, allowing any entity to develop or market drugs based on the covered compounds or derivatives without infringement concerns.
Q3: Are similar patents still active or relevant today?
A3: Many derivative patents continue to be active, focusing on specific modifications, formulations, or uses inspired by the original patent.
Q4: How do strategic patent filings extend protection beyond this patent?
A4: By filing continuation and division applications for specific derivatives, formulations, and methods, companies can extend exclusivity even after the original patent expires.
Q5: What are the key considerations for developing drugs based on this patent's scope?
A5: Understanding the chemical scope and claims, evaluating patent landscape and freedom-to-operate, and innovating beyond the claims with new compounds or formulations.
References
[1] U.S. Patent 5,916,893. (1999). Compounds and methods for serotonin receptor modulation.
[2] WIPO. (2023). Patent landscape reports on serotonergic agents.
[3] European Patent Office. (2023). Related patent family filings and legal status.
[4] USPTO Patent Full-Text and Image Database. (2023). Patent prosecution and citation history.
[5] Johnson, R. et al. (2020). Advances in serotonin receptor modulators: Structural modifications and therapeutic applications. Journal of Medicinal Chemistry.
